Heart Disease

What Causes High Blood Pressure?

Blood pressure is the term used to describe the pressure exerted on the arterial walls as blood flows through them. This pressure is at its highest when the heart contracts and pumps blood through the arteries and is called the systolic pressure.

Heart Failure Terminology

What are Drug-Eluting Stents?

Cardiogenic Shock Treatment

Cardiac Pharmaceutical Agents

Carotid Artery Stenosis Diagnosis

Drug-Eluting Stent Alternatives

Artificial Intelligence in Cardiology

What is Cardiogenic Shock?

Hypertension Diagnosis

Hypertrophic Cardiomyopathy Treatments

What is Chronic Obstructive Pulmonary Disease?

See more featured articles »

Link between Bisphenol A and Increase in Blood Pressure

Coronary Artery Disease Angina

Myocardial T1 and T2 Mapping

Obesity and Blood Pressure

Foods that Reduce Heartburn (Acid Reflux)

Diagnosis of Hypoplastic Left Heart Syndrome

Cardiogenic Shock Symptoms

Drug-Eluting Stent Indications

High Blood Pressure Hypertension

Heart attack and cardiac arrest difference

What is a Heart Attack?

What Causes A Heart Attack?

Hypertrophic Cardiomyopathy (HCM)

Percutaneous Closure Procedure

Carotid Artery Stenosis Treatment

Coronary Artery Disease Treatment

Prognosis for Hypoplastic Left Heart Syndrome

Drug-Eluting Stent Risks

Heartburn (Acid Reflux) Prevention

Hypoplastic Left Heart Syndrome (HLHS)

Heart Attack Questions

Heartburn (Acid Reflux) Triggers

Cardiovascular Benefits of Blueberries

Heart Failure Diagnosis

Cardiothoracic Surgery

Hidden Signs of Heart Problems

Cardiovascular Disease Diagnosis

Lowering Risk for Cardiovascular Disease

Heart Rate Reserve

Photoplethysmography (PPG) for Heart Disease

Chronic Obstructive Pulmonary Disease Symptoms

Heart Failure Management

Causes and Symptoms of Hypoplastic Left Heart Syndrome

What is Heart Rate?

Heart Disease Biomarkers and Screening Tests

Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)

Anti-Hypertensive Drugs

Pulmonary Rehabilitation for COPD

Hypercholesterolemia and Hypocholesterolemia

Heart Attack Symptoms

Heartburn (Acid Reflux) Treatments

What is Obesity?

Coronary Artery Disease Characteristics

Surviving Heart Attack

Hypertrophic Cardiomyopathy Screening

Hypertension Treatment

Coronary Artery Disease and Omega-3 Fatty Acids

High Blood Pressure in Children

Chronic Obstructive Pulmonary Disease Diagnosis

What is Cardiovascular Disease?

What is high cholesterol?

Heart Failure Symptoms

What is Heartburn (Acid Reflux)?

What is Coronary Artery Disease?

Cardiothoracic Imaging Techniques

Causes of Heartburn (Acid Reflux)

Heart Failure Classification

Chronic Obstructive Pulmonary Disease Process

Treatment of Hypoplastic Left Heart Syndrome

What is Carotid Artery Stenosis?

What is Cholesterol?

Chronic Obstructive Pulmonary Disease Causes

Chronic Obstructive Pulmonary Disease Management

Structure and Function of the Heart

Coronary Artery Disease and Aspirin

Obesity in Adults

How the Heart Pumps Blood

Heart Rate Abnormalities

History of Chronic Obstructive Pulmonary Disease

Coronary Artery Disease Prevention

COPD and Sleep Apnea

LDL Cholesterol and Heart Disease

Hypertension Symptoms and Effects

Coronary Artery Disease Pathophysiology

Heart Failure

Hypertension Risk Factors

Coronary Artery Disease Preventive Diets

Diagnostic Tests for Hypertrophic Cardiomyopathy

Chronic Obstructive Pulmonary Disease Treatment

Cardiovascular Drugs

Cardiology Procedures

Target Heart Rate

Heart Failure Causes

Dieting for Obese Children

Heart Attack Diagnosis

Cholesterol Physiology

Why is Visceral Fat Dangerous?

Heart Attack Treatment

Drug-Eluting Stent Design

Abdominal Obesity and the Metabolic Syndrome

High Cholesterol and Stroke Risk

Heart Failure Prognosis

Coronary Artery Disease Risk Factors

How is Acid Reflux Diagnosed?

What is Cardiology?

Hypertrophic Cardiomyopathy Symptoms and Causes

Heart Failure Pathophysiology

Cardiovascular Disease Research

Obesity and Metabolic Syndrome

Cardiogenic Shock Diagnosis

Latest Heart Disease News and Research

GLP-1 therapy associated with more dizziness and fainting

Northwestern Medicine scientists have identified a safety concern associated with GLP-1 drugs. Using health record data, the research team tracked more than 42,000 adults already taking at least two types of blood pressure medications.

14 Jun 2026

Physical activity declines after starting GLP-1 obesity treatments

Adults with obesity losing weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which is essential to protect muscle, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

14 Jun 2026

AI model could improve screening for primary aldosteronism

A study of a new AI model examining 30 years of routine electronic health records (EHR) data could improve screening for primary aldosteronism, a leading cause of high blood pressure that is often unrecognized but increases patients' risk of cardiovascular complications, according to a study being presented Saturday at ENDO 2026, the Endocrine Society's annual meeting in Chicago, Ill.

14 Jun 2026

Comprehensive food regulations lower obesity risk among children

Chile's complementary set of policies targeting food products high in fat, salt and sugar plausibly reduces the risk of school age children being overweight or having obesity, finds a study published in The Lancet.

11 Jun 2026

FemTech innovations are transforming women's health care worldwide

JMIR Publications released a News and Perspectives story on technological innovations in women's health care.

11 Jun 2026

Trial finds prunes do not outperform calcium and vitamin D for male bone density

A one-year randomized trial found that daily prune supplementation did not improve total or lumbar spine bone mineral density in older men susceptible to, or with, osteopenia. Although some bone turnover biomarkers differed between prune and control groups, these changes did not translate into measurable bone density benefits beyond calcium and vitamin D3 supplementation.

11 Jun 2026

Oral GLP-1 drug elecoglipron helps adults lose up to 11.8% body weight

Once-daily oral elecoglipron produced dose-dependent weight loss in adults with obesity or overweight without diabetes, with mean reductions reaching 10.5% at 26 weeks and 11.8% at 36 weeks in the highest-dose weekly-titration group. The phase 2 trial found no evidence of a weight-loss plateau by 36 weeks, while gastrointestinal adverse events were common but generally manageable.

11 Jun 2026

BU professor to examine the role of postpartum hypertension on recurrent HDP risk

Samantha Parker Kelleher, along with researchers at BU School of Public Health and Boston Medical Center, will examine the role of high blood pressure during the postpartum period on the risk of developing recurrent hypertensive disorders of pregnancy, such as preeclampsia and gestational hypertension.

11 Jun 2026

Intravenous statins during heart attack reduce cardiac muscle damage

Reducing the damage sustained by the heart during a myocardial infarction remains one of the major challenges in cardiology, even when the blocked coronary artery is reopened in a timely manner.

11 Jun 2026

Running a marathon triggers measurable heart changes

Acute cardiac responses to marathon running include biomarker spikes and structural changes, though their long-term impact on heart health needs further study.

11 Jun 2026

Novel report uses two-eyed seeing to bridge Indigenous health knowledge

A novel study among Indigenous communities in Canada utilizing sharing circles as the primary method of qualitative data collection shows that heart health is shaped by emotional, spiritual, social, and systemic factors, with trauma strongly influencing how care is accessed and trusted.

11 Jun 2026

One drink a day may be the new upper limit for safer alcohol guidance

A US cause-specific modeling study found no net protective health effect from low-level alcohol consumption, with lifetime alcohol-attributable mortality risk rising above 1 in 1,000 at just over 6.5 drinks per week for males and 7.0 drinks per week for females.

11 Jun 2026

Study identifies an important driver of inflammatory bowel disease

Researchers at the Nuffield Department of Medicine, University of Oxford, together with Newcastle University's Translational and Clinical Research Institute and the Department of Immunology at Cambridge University Hospitals NHS Foundation Trust, have identified an important driver of inflammatory bowel disease (IBD).

10 Jun 2026

More movement and less sitting benefit pregnant women

Women who engage in light physical activity and lessen their sedentary time may significantly reduce the risk of key health problems during pregnancy, according to a new University of Iowa-led study.

10 Jun 2026

Short-term fasting may reduce inflammation linked to gum disease

People who follow a short-term low-calorie diet may have reduced markers of inflammation associated with gum disease.

10 Jun 2026

Proactive brain training strengthens mental wellness before challenges arise

A new study recently published in the peer-reviewed journal Frontiers in Psychology challenges the traditional, reactive model of mental health care by demonstrating that proactive brain training can strengthen the human mind before mental health challenges take root.

10 Jun 2026

Low blood pressure shows strongest link to Alzheimer's disease

Numerous types of cardiovascular disease and CVD risk factors were linked to a higher risk of Alzheimer's disease, with low blood pressure showing the strongest connection, according to a new analysis published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

10 Jun 2026

Review explores impact of extreme endurance running on heart health

Changes to the heart linked to marathon running vary by age, sex, and training level, finds a synthesis of the available data, published in the open access journal BMJ Open Sport & Exercise Medicine.

10 Jun 2026

GLP-1 medicines may cut clot-related risks in chronically inflamed patients

In a target trial emulation using OneFlorida+ electronic health record data, GLP-1 receptor agonist use in adults with obesity and autoimmune disease was linked to lower hazards of pulmonary embolism, venous thromboembolism, stroke/TIA, emergency department visits, and all-cause mortality.

10 Jun 2026

Statins may help prevent frailty in older adults

Researchers at Mass General Brigham have demonstrated that older U.S. veterans who initiated statin therapy were significantly less likely to develop frailty over time, suggesting that the cholesterol-lowering medications may have healthy aging benefits beyond cardiovascular disease prevention. Results are published in the European Heart Journal.

9 Jun 2026